title: Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.
abstract: The attenuation of brain edema is a major therapeutic target after traumatic brain injury (TBI). Vasopressin (AVP) is well known to play a major role in the regulation of brain water content and vasoendothelial functions and to be involved in brain edema formation. Therefore, the aim of the current study was to analyze the antiedematous efficacy of a clinically relevant, nonpeptidic AVP V1a and V2 receptor antagonists. C57Bl6 mice were subjected to controlled cortical impact (CCI) and V1a or V2 receptors were inhibited by using the highly selective antagonists SR-49059 or SR-121463A either by systemic (intraperitoneal, IP) or intracerebroventricular (ICV) application. After 24 h, brain edema, intracranial pressure (ICP), and contusion volume were assessed. Systemically applied AVP receptor antagonists could not reduce secondary lesion growth. In contrast, ICV administration of AVP V1a receptor antagonist decreased brain edema formation by 68%, diminished post-traumatic increase of ICP by 46%, and reduced secondary contusion expansion by 43% 24 h after CCI. The ICV inhibition of V2 receptors resulted in significant reduction of post-traumatic brain edema by 41% 24 h after CCI, but failed to show further influence on ICP and lesion growth. Hence, centrally applied vasopressin V1a receptor antagonists may be used to reduce brain edema formation after TBI.
authors.affiliation: 1 Laboratory of Experimental Neurosurgery, University of Munich Medical Center-Grosshadern, Ludwig-Maximilians-University , Munich, Germany .
authors.forename: Sandro M
authors.initials: SM
authors.lastname: Krieg
authors.forename: Sebastian
authors.initials: S
authors.lastname: Sonanini
authors.forename: Nikolaus
authors.initials: N
authors.lastname: Plesnila
authors.forename: Raimund
authors.initials: R
authors.lastname: Trabold
mesh_terms: D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists / Q000494:pharmacology*; D001929:Brain Edema / Q000473:pathology*; D001930:Brain Injuries / Q000473:pathology*; D004195:Disease Models, Animal; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009025:Morpholines / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D017483:Receptors, Vasopressin / Q000187:drug effects / Q000378:metabolism*; D013141:Spiro Compounds / Q000494:pharmacology*
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D007211:Indoles; D009025:Morpholines; D011759:Pyrrolidines; D017483:Receptors, Vasopressin; D013141:Spiro Compounds; C103281:satavaptan; C082134:relcovaptan
keywords: CBF; arginine vasopressin; brain edema; traumatic brain injury
references.citation: J Physiol Pharmacol. 2006 Nov;57 Suppl 11:161-7
references.pmid: 17244947
references.citation: Neurosurgery. 1982 Sep;11(3):402-7
references.pmid: 7133357
references.citation: Cerebrovasc Dis. 2001;11(2):113-8
references.pmid: 11223663
references.citation: Adv Exp Med Biol. 1998;449:455-65
references.pmid: 10026839
references.citation: J Endocrinol Invest. 2008 Nov;31(11):996-1000
references.pmid: 19169056
references.citation: J Clin Invest. 1993 Jul;92(1):224-31
references.pmid: 8392086
references.citation: Brain Res. 2006 Feb 3;1071(1):237-44
references.pmid: 16412395
references.citation: Endocrinology. 1994 Oct;135(4):1511-28
references.pmid: 7925112
references.citation: Ann Neurol. 1981 Feb;9(2):182-4
references.pmid: 7235633
references.citation: Acta Neurochir Suppl (Wien). 1994;60:502-4
references.pmid: 7976630
references.citation: Fed Proc. 1986 Aug;45(9):2318-22
references.pmid: 2874053
references.citation: Acta Neurochir Suppl (Wien). 1990;51:14-6
references.pmid: 2151007
references.citation: J Neurotrauma. 2006 Jul;23(7):1083-93
references.pmid: 16866621
references.citation: J Neurotrauma. 2008 Dec;25(12):1459-65
references.pmid: 19118456
references.citation: Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6783-7
references.pmid: 7624319
references.citation: J Cereb Blood Flow Metab. 2005 Aug;25(8):1012-9
references.pmid: 15744246
references.citation: Neurocrit Care. 2012 Jun;16(3):470-7
references.pmid: 22528282
references.citation: J Cereb Blood Flow Metab. 2008 Jul;28(7):1353-60
references.pmid: 18414497
references.citation: J Cereb Blood Flow Metab. 1992 Jul;12(4):681-90
references.pmid: 1618946
references.citation: J Histochem Cytochem. 1980 Apr;28(4):357-60
references.pmid: 6989899
references.citation: J Head Trauma Rehabil. 2010 Mar-Apr;25(2):72-80
references.pmid: 20234226
references.citation: J Pharmacol Exp Ther. 2002 Mar;300(3):1122-30
references.pmid: 11861823
references.citation: J Neurol Neurosurg Psychiatry. 1981 Mar;44(3):216-9
references.pmid: 7229644
references.citation: Stroke. 2012 Jan;43(1):227-32
references.pmid: 21998059
references.citation: Am J Physiol. 1986 Sep;251(3 Pt 2):F485-9
references.pmid: 3752258
references.citation: J Neurosci Methods. 2007 Jan 30;159(2):261-7
references.pmid: 16945419
references.citation: Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E1175-6
references.pmid: 10905857
references.citation: Neurosurgery. 1999 Jan;44(1):148-54; discussion 154-5
references.pmid: 9894975
references.citation: Cell Tissue Res. 1999 Dec;298(3):383-95
references.pmid: 10639729
references.citation: J Neurotrauma. 2003 Dec;20(12):1307-14
references.pmid: 14748979
references.citation: Neurosurgery. 1984 Apr;14(4):436-41
references.pmid: 6728146
references.citation: Chin Med J (Engl). 1991 Jun;104(6):480-3
references.pmid: 1651829
references.citation: Stroke. 1992 Dec;23(12):1767-73; discussion 1773-4
references.pmid: 1448828
references.citation: J Clin Invest. 1996 Dec 15;98(12):2729-38
references.pmid: 8981918
references.citation: Proc Natl Acad Sci U S A. 1984 Nov;81(22):7248-52
references.pmid: 6095279
references.citation: Clin Lab Med. 1998 Mar;18(1):39-64
references.pmid: 9523063
references.citation: Am J Physiol. 1990 Jan;258(1 Pt 2):R94-8
references.pmid: 2137302
references.citation: Differentiation. 1995 Oct;59(3):163-9
references.pmid: 7589900
references.citation: Neurochem Int. 2011 Mar;58(4):542-8
references.pmid: 21256175
references.citation: Brain Res. 1978 Mar 17;143(1):191-4
references.pmid: 415801
references.citation: Am J Physiol. 1988 Jul;255(1 Pt 2):H70-6
references.pmid: 3394828
references.citation: J Neurosci. 2001 May 1;21(9):3045-51
references.pmid: 11312289
references.citation: Can J Physiol Pharmacol. 1992;70 Suppl:S367-73
references.pmid: 1295687
references.citation: Brain Res. 2001 Aug 10;910(1-2):19-28
references.pmid: 11489250
references.citation: Br J Pharmacol. 2001 Apr;132(8):1837-44
references.pmid: 11309256
references.citation: Chin J Traumatol. 2007 Apr;10(2):90-3
references.pmid: 17371619
references.citation: Q Rev Biol. 2012 Jun;87(2):89-127
references.pmid: 22696939